Unknown

Dataset Information

0

JAK2 activation promotes tumorigenesis in ALK-negative anaplastic large cell lymphoma via regulating oncogenic STAT1-PVT1 lncRNA axis.

ABSTRACT:

SUBMITTER: Le K 

PROVIDER: S-EPMC7955124 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

JAK2 activation promotes tumorigenesis in ALK-negative anaplastic large cell lymphoma via regulating oncogenic STAT1-PVT1 lncRNA axis.

Le Kang K   Wellik Linda E LE   Maurer Matthew J MJ   McPhail Ellen D ED   Witzig Thomas E TE   Gupta Mamta M  

Blood cancer journal 20210312 3

Similar Datasets

Unknown Regulation of CD45 phosphatase by oncogenic ALK in anaplastic large cell lymphoma.
| S-EPMC9869957 | biostudies-literature
Unknown Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma.
| S-EPMC8076043 | biostudies-literature
Unknown Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma.
| S-EPMC8271116 | biostudies-literature
Unknown Chemically Induced Degradation of Anaplastic Lymphoma Kinase (ALK).
| S-EPMC6294449 | biostudies-literature
Unknown ALK-positive anaplastic large cell lymphoma in adults.
| S-EPMC10467138 | biostudies-literature
Unknown From Pathology to Precision Medicine in Anaplastic Large Cell Lymphoma Expressing Anaplastic Lymphoma Kinase (ALK+ ALCL).
| S-EPMC5664077 | biostudies-literature
Unknown Proteolysis Targeting Chimeras (PROTACs) of Anaplastic Lymphoma Kinase (ALK).
| S-EPMC5924614 | biostudies-literature
Unknown Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma.
| S-EPMC8814675 | biostudies-literature
Unknown Holistic View of ALK TKI Resistance in ALK-Positive Anaplastic Large Cell Lymphoma.
| S-EPMC8862178 | biostudies-literature
Unknown Anaplastic thyroid cancers harbor novel oncogenic mutations of the ALK gene.
| S-EPMC3129369 | biostudies-literature